Israel Englander Better Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.14 - $0.39 $18,024 - $50,212
128,749 New
128,749 $25,000
Q1 2023

May 15, 2023
BUY
$0.64 - $1.45 $9,556 - $21,651
14,932 Added 128.46%
26,556 $19,000
Q4 2022

Feb 14, 2023
SELL
$1.1 - $1.74 $2,895 - $4,579
-2,632 Reduced 18.46%
11,624 $13,000
Q3 2022

Nov 14, 2022
BUY
$1.53 - $2.77 $21,811 - $39,489
14,256 New
14,256 $25,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0
View Full List

About Better Therapeutics, Inc.

BTTX Quotes by TradingView
  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email